IN THE NEWS

CDMO

30January2026

Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US

This overview explores Ritedose, the largest U.S. pharmaceutical CDMO, and how its aseptic Blow-Fill-Seal technology supports large-scale branded and generic drug manufacturing.

Ritedose Blow-Fill-Seal Technology | Aerial view of Ritedose pharmaceutical manufacturing facilities in Columbia, South Carolina, showcasing the largest U.S. Blow-Fill-Seal CDMO.

16January2026

How Ritedose Supports a Stable and Reliable Medication Supply

Learn how Ritedose safeguards patients’ access to critical medications with responsive, high-quality pharmaceutical manufacturing.

Automated pharmaceutical warehouse with a yellow robotic arm stacking cardboard boxes, illustrating Ritedose’s focus on transparency, efficiency, and solutions for drug shortages.

24September2025

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

Ritedose is investing $17M to expand its cGMP labs, adding a 10,000 sq. ft. analytical chemistry facility and a 6,000 sq. ft. microbiology expansion to boost drug development and CDMO capabilities.

male scientist mixing chemicals in lab with text overlay "$17M expansion"

16September2025

How Blow-Fill-Seal Technology Ensures Sterile Medication Delivery

Discover how Ritedose leads the industry in delivering safe, scalable, and contamination-free drug products through advanced BFS innovation.

18June2025

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

COLUMBIA, SC, June 18, 2025 – The Ritedose Corporation, a leading pharmaceutical manufacturer specializing in Blow-Fill-Seal (BFS) technology, today unveiled its new distribution and logistics facility at Performance Park during a ribbon-cutting ceremony. The grand opening event included Ritedose CEO…

Stakeholders open the Ritedose distribution and logistics facility at Performance Park. L–R: Brian Taylor, VP Business Development, Miller Valentine Construction Jeff Ruble, Director, Richland County Economic Development Ashely Teasdel, Deputy Secretary, SC Dept. of Commerce Jody Chastain, CEO, Ritedose Jesica Mackey, Richland County Council District 9 Daniel Rickenmann, Mayor, City of Columbia Ronald Rhames, Fmr. President, Midlands Technical College Greg Little, President, Midlands Technical College

15April2025

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

COLUMBIA, S.C. April 16, 2025 – Anticipating a rising need for individually wrapped vial medication manufacturing, The Ritedose Corporation, Inc. (Ritedose) is adding a seventh Syntegon packaging line to its state-of-the-art manufacturing facility that will double the company’s capacity.

16September2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

September 17, 2024 — The Ritedose Corporation, Inc. (Ritedose), the largest CDMO in the United States specializing in sterile Blow Fill Seal (BFS) production of unit dose solutions for the ophthalmic and respiratory markets, is proud to partner with Verona…

11July2024

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications

COLUMBIA, S.C. June 20, 2024 – The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces a significant expansion of its production capabilities to meet the demand for ophthalmic…

18January2022

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

COLUMBIA, S.C. (January 18) — The Ritedose Corporation has announced the development of and plans to commercialize the first new way to dispense single-dose liquid medications in two decades. After five years of R&D, the Columbia-based developer of blow-fill-seal unit…

4January2022

Novo Holdings to acquire Ritedose

COPENHAGEN, Denmark, Jan. 4, 2022 /PRNewswire/ – Founded in 1995 and headquartered in Columbia, S.C., The Ritedose Corporation (“Ritedose”) is a leading sterile pharmaceutical manufacturer, specialising in the use of blow-fill-seal (BFS) technology. Ritedose provides outsourced development and manufacturing…

3August2021

Ritedose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability

Engineering for Surge Development Columbia, SC – The Ritedose Corporation, the company born from the inventors of Blow-Fill-Seal (BFS) technology, has implemented engineering innovations that will now allow the country’s leading BFS Contract Development and Manufacturing Organization (CDMO) to increase…

FEATURED NEWS

30th January 2026

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

16th September 2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

11th July 2024

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand f…

18th January 2022

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

4th January 2022

Novo Holdings to acquire Ritedose

RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

CDMO

Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US

How Ritedose Supports a Stable and Reliable Medication Supply

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

How Blow-Fill-Seal Technology Ensures Sterile Medication Delivery

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

Novo Holdings to acquire Ritedose

Ritedose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability

FEATURED NEWS

Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US

How Ritedose Supports a Stable and Reliable Medication Supply

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

How Blow-Fill-Seal Technology Ensures Sterile Medication Delivery

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand f…

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

Novo Holdings to acquire Ritedose

RECEIVE THE LATEST NEWS

TAGS CLOUD

Quick Links

Receive the latest news.

CDMO

FEATURED NEWS

RECEIVE THE LATEST NEWS

TAGS CLOUD

Tags

Quick Links

Receive the latest news.